Gene · 442915
Papers1,407
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 1,407
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Whole-Transcriptome Profiling of Ovarian Tissues in Gilts with Normal Estrus and Follicular Cyst-Associated Anestrus. | Int J Mol Sci | 2026 | 42589503 | PubTator, text mining | PubMed |
| circLDHC controls sertoli cell maturation and metabolic remodeling through the miR-370-AR axis. | Mol Cell Endocrinol | 2026 | 42492653 | PubTator, text mining | PubMed |
| Protective effect of ischemic preconditioning against hepatic ischemia-reperfusion injury and associated remote organ damage. | World J Gastrointest Surg | 2026 | 41809327 | PubTator, text mining | PubMed |
| Epigenetic dysregulation of B‑cells in autoimmune diseases and lymphomas (Review). | Int J Mol Med | 2026 | 41574706 | PubTator, text mining | PubMed |
| In-silico pharmacological insights into the therapeutic potential of microRNAs for microplastic-associated cancers. | Front Cell Dev Biol | 2025 | 41378310 | PubTator, text mining | PubMed |
Significant Association Between Abundance of Gut Microbiota and Plasma Levels of microRNAs in Individuals with Metabolic Syndrome and Their Potential as Biomarkers for Metabolic Syndrome: A Pilot Study. | Genes (Basel) | 2025 | 41153378 | PubTator, text mining | PubMed |
| Refining Flow Cytometry-based Sorting of Plasma-derived Extracellular Vesicles. | Biol Proced Online | 2025 | 40836218 | PubTator, text mining | PubMed |
| Progress of targeted FOX family therapy in ovarian cancer. | Front Pharmacol | 2025 | 40746724 | PubTator, text mining | PubMed |
| Retraction Notice to: hsa_circ_0061140 Knockdown Reverses FOXM1- Mediated Cell Growth and Metastasis in Ovarian Cancer through miR-370 Sponge Activity. | Mol Ther Nucleic Acids | 2025 | 40606643 | PubTator, text mining | PubMed |
| [Omics Study of Ovarian Malignancies: From Urine Metabolomic Profile to Minimally Invasive MicroRNA Markers]. | Mol Biol (Mosk) | 2025 | 40542633 | PubTator, text mining | PubMed |
| AAT-MSC-EVs: Novel implications for suppressing ferroptosis, fibrosis and pain associated with chronic pancreatitis. | Mol Ther | 2025 | 40121529 | PubTator, text mining | PubMed |
| Current perspectives on the dynamic culture of mesenchymal stromal/stem cell spheroids. | Stem Cells Transl Med | 2025 | 39737878 | PubTator, text mining | PubMed |
| Retraction notice to 'MiR-370 functions as oncogene in melanoma by direct targeting pyruvate dehydrogenase B' [Biomedicine & Pharmacotherapy, Volume 90 (2017) Pages 278-286]. | Biomed Pharmacother | 2024 | 39039009 | PubTator, text mining | PubMed |
| The diagnostic accuracy of serum and plasma microRNAs in detection of cervical intraepithelial neoplasia and cervical cancer: A systematic review and meta-analysis. | Gynecol Oncol Rep | 2024 | 38939506 | PubTator, text mining | PubMed |
| Extracellular vesicles secreted by 3D tumor organoids are enriched for immune regulatory signaling biomolecules compared to conventional 2D glioblastoma cell systems. | Front Immunol | 2024 | 38726003 | PubTator, text mining | PubMed |
| Dysregulation of TCONS_00006091 contributes to the elevated risk of oral squamous cell carcinoma by upregulating SNAI1, IRS and HMGA2. | Sci Rep | 2024 | 38671227 | PubTator, text mining | PubMed |
| The role of mir96 in predicting CTC status and prognostic evaluation in gastric cancer patients. | Cell Mol Biol (Noisy-le-grand) | 2024 | 38430012 | PubTator, text mining | PubMed |
| The homologous tumor-derived-exosomes loaded with miR-1270 selectively enhanced the suppression effect for colorectal cancer cells. | Cancer Med | 2024 | 38197582 | PubTator, text mining | PubMed |
| Mechanisms of immune checkpoint inhibitors: insights into the regulation of circular RNAS involved in cancer hallmarks. | Cell Death Dis | 2024 | 38177102 | PubTator, text mining | PubMed |
| Circulating long non-coding RNA EWSAT1 acts as a liquid biopsy marker for esophageal squamous cell carcinoma: A pilot study. | Noncoding RNA Res | 2024 | 38028735 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/442915/papers